AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 20 filers reported holding AEGERION PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $425,000 | -15.5% | 653,000 | 0.0% | 0.02% | -20.0% |
| Q1 2018 | $503,000 | -2.9% | 653,000 | 0.0% | 0.02% | 0.0% |
| Q4 2017 | $518,000 | +0.2% | 653,000 | 0.0% | 0.02% | 0.0% |
| Q3 2017 | $517,000 | -1.3% | 653,000 | 0.0% | 0.02% | 0.0% |
| Q2 2017 | $524,000 | -0.8% | 653,000 | 0.0% | 0.02% | -21.9% |
| Q1 2017 | $528,000 | -57.8% | 653,000 | -62.7% | 0.03% | -52.9% |
| Q4 2016 | $1,250,000 | +6.8% | 1,753,000 | 0.0% | 0.07% | +19.3% |
| Q3 2016 | $1,170,000 | +16.1% | 1,753,000 | 0.0% | 0.06% | -14.9% |
| Q2 2016 | $1,008,000 | +12.8% | 1,753,000 | 0.0% | 0.07% | +21.8% |
| Q1 2016 | $894,000 | -68.6% | 1,753,000 | -58.8% | 0.06% | -67.5% |
| Q4 2015 | $2,844,000 | +16.4% | 4,253,000 | +30.7% | 0.17% | +17.4% |
| Q3 2015 | $2,443,000 | – | 3,253,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 1,760,000 | $898,000 | 1.12% |
| Telemetry Investments, L.L.C. | 6,000,000 | $3,049,000 | 0.89% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 54,500,000 | $27,693,000 | 0.46% |
| ZAZOVE ASSOCIATES LLC | 15,070,000 | $7,761,000 | 0.37% |
| ACUTA CAPITAL PARTNERS, LLC | 1,000,000 | $508,000 | 0.28% |
| Tekla Capital Management LLC | 13,000,000 | $6,606,000 | 0.28% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 26,000,000 | $13,910,000,000 | 0.26% |
| Castle Creek Arbitrage, LLC | 4,000,000 | $2,081,000 | 0.17% |
| WOLVERINE ASSET MANAGEMENT LLC | 10,934,000 | $5,558,000 | 0.16% |
| Baker Brothers Advisors | 26,517,000 | $13,526,000 | 0.14% |